z-logo
open-access-imgOpen Access
Development of molecular inhibitor nanoformulations for cancer therapy
Author(s) -
Paige Baldwin
Publication year - 2019
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.17760/d20317945
Subject(s) - combination therapy , toxicity , ovarian cancer , medicine , drug delivery , pharmacology , parp inhibitor , drug , cancer , efficacy , cancer research , chemistry , poly adp ribose polymerase , biochemistry , organic chemistry , polymerase , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom